Literature DB >> 3422337

Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody.

J W Ward1, S D Holmberg, J R Allen, D L Cohn, S E Critchley, S H Kleinman, B A Lenes, O Ravenholt, J R Davis, M G Quinn.   

Abstract

Since early 1985, blood donations in the United States have been screened for antibody to human immunodeficiency virus (HIV). To identify instances of HIV transmission by antibody-negative donations, we investigated 13 persons seropositive for HIV who had received blood from 7 donors who were screened as negative for HIV antibody at the time of donation. Twelve of the 13 recipients had no identifiable risk factors for HIV infection other than the transfusions they had received. On evaluation 8 to 20 months after transfusion, HIV-related illnesses had developed in three recipients, and the acquired immunodeficiency syndrome had developed in one. All seven donors were found to be infected with HIV. On interview, six reported a risk factor for HIV infection, and five had engaged in high-risk activities or had had an illness suggestive of acute retroviral syndrome within the four months preceding their HIV-seronegative donation. Thus, these donors had apparently been infected only recently, and so were negative at the time of blood donation according to available antibody tests. We conclude that there is a small but identifiable risk of HIV infection for recipients of screened blood. To minimize this risk, the reasons for deferral of donation need to be communicated more effectively to blood donors who are at high risk of HIV infection, and new assays that detect HIV infection earlier should be evaluated for their effectiveness in screening donated blood.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Americas; Developed Countries; Developing Countries; Diseases; Equipment And Supplies; Examinations And Diagnoses; Hiv Infections; Laboratory Examinations And Diagnoses; Laboratory Procedures; North America; Northern America; Population At Risk; Research Methodology; Research Report; United States; Viral Diseases

Mesh:

Substances:

Year:  1988        PMID: 3422337     DOI: 10.1056/NEJM198802253180803

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  40 in total

1.  Performance of a multiplex qualitative PCR LCx assay for detection of human immunodeficiency virus type 1 (HIV-1) group M subtypes, group O, and HIV-2.

Authors:  K Abravaya; C Esping; R Hoenle; J Gorzowski; R Perry; P Kroeger; J Robinson; R Flanders
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 2.  Haematology.

Authors:  N T O'Connor
Journal:  Postgrad Med J       Date:  1990-08       Impact factor: 2.401

Review 3.  Molecular techniques in the diagnosis of human infectious diseases.

Authors:  U Desselberger; K Collingham
Journal:  Genitourin Med       Date:  1990-10

Review 4.  Transmission of hepatitis and AIDS: risks for the anaesthetist and the patient.

Authors:  C A Trépanier
Journal:  Can J Anaesth       Date:  1991-05       Impact factor: 5.063

5.  The donation and sale of blood by intravenous drug users.

Authors:  D D Chitwood; J B Page; M Comerford; J A Inciardi; C B McCoy; E Trapido; S H Lai
Journal:  Am J Public Health       Date:  1991-05       Impact factor: 9.308

6.  Blood transfusion and haemostatic management in the perioperative period.

Authors:  A J McIntyre
Journal:  Can J Anaesth       Date:  1992-05       Impact factor: 5.063

7.  Statement on sources of blood for transfusion. Committee on Public Health.

Authors: 
Journal:  Bull N Y Acad Med       Date:  1988 Jul-Aug

8.  TaqMan 5'-nuclease human immunodeficiency virus type 1 PCR assay with phage-packaged competitive internal control for high-throughput blood donor screening.

Authors:  C Drosten; E Seifried; W K Roth
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

9.  Detection of human immunodeficiency virus type 1 (HIV-1) RNA in pools of sera negative for antibodies to HIV-1 and HIV-2.

Authors:  P A Morandi; G A Schockmel; S Yerly; P Burgisser; P Erb; L Matter; R Sitavanc; L Perrin
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

10.  The effects of the AIDS epidemic on the safety of the nation's blood supply.

Authors:  J C Petricciani; J S Epstein
Journal:  Public Health Rep       Date:  1988 May-Jun       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.